Showing results (1-10 of 475) with videos related to
Sort By:
Pageof 48
Plos One|July 24, 2008
A visual metaphor describing neural dynamics in schizophreniaNico J M van Beveren, Lieuwe de HaanEuropean Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 21, 2006
Schizophrenia-associated neural growth factors in peripheral blood. A reviewNico J M van Beveren, Job-Jeroen van der Spelt, Lieuwe de Haan, et al.Psychological Medicine|March 3, 2021
Changes in peripheral blood compounds following psychopharmacological treatment in drug-naïve first-episode patients with either schizophrenia or major depressive disorder: a meta-analysisNuray Çakici, Arjen L Sutterland, Brenda W J H Penninx, et al.Psychiatry Research|October 17, 2012
Red blood cell polyunsaturated fatty acids measured in red blood cells and schizophrenia: a meta-analysisWendela P Hoen, Jeroen G Lijmer, Marinus Duran, et al.Schizophrenia Research|May 28, 2025
Distribution of red blood cell fatty acids in stable patients with a schizophrenia spectrum disorder and healthy controlsGwendolyn Schoemaker, Roel J T Mocking, Suzanne Medema, et al.Brain, Behavior, and Immunity|April 25, 2020
Altered peripheral blood compounds in drug-naïve first-episode patients with either schizophrenia or major depressive disorder: a meta-analysisNuray Çakici, Arjen L Sutterland, Brenda W J H Penninx, et al.Psychiatry Research|February 1, 2025
Potential benefits of ketone therapy as a novel immunometabolic treatment for schizophreniaKarin Huizer, Shubham Soni, Mya A Schmidt, et al.Plos One|March 7, 2012
Marked reduction of AKT1 expression and deregulation of AKT1-associated pathways in peripheral blood mononuclear cells of schizophrenia patientsNico J M van Beveren, Gabrielle H S Buitendijk, Sigrid Swagemakers, et al.Nederlands Tijdschrift Voor Geneeskunde|January 7, 2016
[High mortality following psychosis: not only due to suicide]Lieuwe de HaanEuropean Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 25, 2019
Increased serum levels of leptin and insulin in both schizophrenia and major depressive disorder: A cross-disorder proteomics analysisNuray Çakici, Mariska Bot, Femke Lamers, et al.Pageof 48